U.S. flag

An official website of the United States government

NM_000088.4(COL1A1):c.1382G>C (p.Gly461Ala) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Nov 3, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003656153.1

Allele description [Variation Report for NM_000088.4(COL1A1):c.1382G>C (p.Gly461Ala)]

NM_000088.4(COL1A1):c.1382G>C (p.Gly461Ala)

Gene:
COL1A1:collagen type I alpha 1 chain [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q21.33
Genomic location:
Preferred name:
NM_000088.4(COL1A1):c.1382G>C (p.Gly461Ala)
HGVS:
  • NC_000017.11:g.50194800C>G
  • NG_007400.1:g.11840G>C
  • NM_000088.4:c.1382G>CMANE SELECT
  • NP_000079.2:p.Gly461Ala
  • LRG_1:g.11840G>C
  • NC_000017.10:g.48272161C>G
Protein change:
G461A
Links:
dbSNP: rs1598296202
NCBI 1000 Genomes Browser:
rs1598296202
Molecular consequence:
  • NM_000088.4:c.1382G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001159832ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process 2024)
Likely pathogenic
(Nov 3, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV001159832.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The COL1A1 c.1382G>C; p.Gly461Ala variant, to our knowledge, is not described in the medical literature or in gene-specific databases. It is also absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. This variant disrupts the repeating Gly-X-Y sequence motif of the collagen triple helix and is predicted to impair collagen function (Ben Amor 2011). Additionally, another variant at this codon (c.1381G>A; p.Gly461Ser) as well as several other surrounding glycine substitutions in this exon have been reported in individuals affected with osteogenesis imperfect type II and are considered pathogenic (Marini 2007). Based on available information, the p.Gly461Ala variant is considered likely pathogenic. REFERENCES Ben Amor I et al. Genotype-phenotype correlations in autosomal dominant osteogenesis imperfecta. J Osteoporos. 2011; 2011:540178. Marini J et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat. 2007 Mar;28(3):209-21.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024